MANTLE IRRADIATION FOR STAGE I AND STAGE II HODGKIN'S DISEASE – RESULTS OF A 10 YEAR EXPERIENCE

Wiley - Tập 13 Số 2 - Trang 135-140 - 1983
K H Liew1, Juliette Ding2, JP Matthews3, P. J. IRONSIDE4, Geoffrey Beadle5, Ian A. Cooper6, James P. Madigan7, F. G. PARKIN8
1Radiotherapist, Cancer Institute, Melbourne
2Assistant Clinical Hematologist, Cancer Institute, Melbourne
3Statistician, Cancer Institute, Melbourne
4Pathologist, Cancer Institute, Melbourne
5Registrar in Radiotherapy, Cancer Institute, Melbourne
6Consultant Clinical Hematologist, Cancer Institute, Melbourne
7Consultant Radiotherapist, Cancer Institute, Melbourne
8Senior Radiotherapist, Cancer Institute, Melbourne

Tóm tắt

Abstract: One hundred and thirty patients with Stage I and II supradiagphragmatic Hodgkin's disease treated with mantle irradiation alone at the Peter MacCallum Hospital, Melbourne between 1968–1977 were analysed retrospectively. The median followup was 7.4 years with a minimum of three years.There were 64 clinically staged (CS) and 66 pathologically staged (PS) patients. The major difference between the two groups was the transdiaphragmatic relapse which occurred in 33% of CS patients, and 7.5% in PS patients. The actuarial five year relapse free survival (RFS) was 48% for CS patients and 67% for PS patients, but the five year overall survival was 90% for both groups, reflecting the impact of salvage treatment.Avid attention must be given to radiotherapy techniques to minimise local treatment failures. High grade nodular sclerosis Hodgkin's disease is associated with poor RFS even after adjustment has been made for stage and constitutional symptoms (p < 0.003). Further studies will be made on this group of patients who may benefit from combined modality treatment. For PS I and II patients mantle irradiation gives a five year RFS of 67%, thus offering potential for cure in these patients.

Từ khóa


Tài liệu tham khảo

10.1001/jama.1902.62480030024001h

Gilbert R, 1939, Radiotherapy in Hodgkins disease (malignant granulomatosis, Am J Roentgenology, 41, 198

Peters MV, 1950, A study of survivals in Hodgkins disease treated radiologically, Am J Roentgenology, 63, 299

Kaplan HS, 1980, Hodgkins's disease

10.1148/88.6.1162

10.1002/1097-0142(197307)32:1<150::AID-CNCR2820320122>3.0.CO;2-N

10.1038/bjc.1977.1

10.1002/1097-0142(197606)37:6<2813::AID-CNCR2820370637>3.0.CO;2-S

10.1016/0014-2964(79)90138-5

10.1038/bjc.1975.239

10.1016/0360-3016(80)90315-6

10.1002/1097-0142(197903)43:3<1101::AID-CNCR2820430348>3.0.CO;2-3

10.1002/1097-0142(197907)44:1<72::AID-CNCR2820440114>3.0.CO;2-4

10.1016/0002-9343(79)90389-9

10.2214/ajr.120.3.536

10.1111/j.1440-1673.1976.tb02024.x

CrambJ. Department of Physical Sciences Cancer Institute Melbourne. (Personal communication.).

Fletcher GH, 1975, The interplay of radio curability and tolerance in the irradiation of human cancers, J Radio!, 56, 383

10.1148/89.5.919

10.1002/1097-0142(197407)34:1<83::AID-CNCR2820340112>3.0.CO;2-P

10.1002/1097-0142(19801201)46:11<2403::AID-CNCR2820461116>3.0.CO;2-9

10.1002/1097-0142(197809)42:3<1039::AID-CNCR2820420302>3.0.CO;2-R

10.1002/1097-0142(197707)40:1<90::AID-CNCR2820400117>3.0.CO;2-L